Maryland State Retirement & Pension System Invests $1.31 Million in Everus (NYSE:ECG)

Maryland State Retirement & Pension System purchased a new position in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 19,982 shares of the company’s stock, valued at approximately $1,314,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ECG. Forza Wealth Management LLC acquired a new position in shares of Everus during the fourth quarter worth about $336,000. Mendota Financial Group LLC acquired a new position in shares of Everus during the fourth quarter worth about $36,000. SeaCrest Wealth Management LLC acquired a new position in shares of Everus during the fourth quarter worth about $292,000. Hennessy Advisors Inc. purchased a new stake in Everus during the fourth quarter worth about $31,611,000. Finally, Brady Martz Wealth Solutions LLC purchased a new stake in Everus during the fourth quarter worth about $472,000.

Insider Activity at Everus

In related news, Director Edward A. Ryan purchased 1,400 shares of the company’s stock in a transaction that occurred on Tuesday, February 25th. The stock was purchased at an average price of $38.02 per share, with a total value of $53,228.00. Following the completion of the transaction, the director now owns 14,928 shares of the company’s stock, valued at approximately $567,562.56. This trade represents a 10.35 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Maximillian J. Marcy purchased 1,300 shares of the company’s stock in a transaction that occurred on Tuesday, February 25th. The shares were bought at an average cost of $38.99 per share, with a total value of $50,687.00. Following the transaction, the chief financial officer now directly owns 5,508 shares of the company’s stock, valued at $214,756.92. The trade was a 30.89 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 3,750 shares of company stock valued at $153,853.

Analyst Upgrades and Downgrades

ECG has been the topic of a number of research analyst reports. Oppenheimer boosted their price objective on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, January 7th. Wolfe Research initiated coverage on shares of Everus in a report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus decreased their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a report on Thursday, February 13th.

Read Our Latest Report on ECG

Everus Stock Down 2.2 %

Shares of NYSE ECG opened at $39.32 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. The firm has a 50-day simple moving average of $54.38. Everus has a 12-month low of $36.96 and a 12-month high of $77.93.

Everus (NYSE:ECGGet Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, equities analysts predict that Everus will post 2.49 EPS for the current fiscal year.

Everus Profile

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Articles

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.